Key result
Andrographis paniculata and andrographolide lack specific reported results for their clot lysis activity.
Why the study?
Andrographis paniculata and andrographolide have shown cardioprotective effects in animal models, but their clot lysis activity required investigation.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Preliminary clot lysis data on Andrographis paniculata leave therapeutic potential open; clinical trials required before consideration.
Background: Andrographis paniculata and its main components andrographolide (AGL) have been reported for their promising cardio-protective effects in experimental animals. Aim: To investigate clot lysis activity of A. paniculata and AGL.
No takes yet. Share an insight, caveat, or question.
Muhammad Torequl Islam (2020) studied this question. Andrographis paniculata and its pure compound andrographolide were investigated for their clot lysis activity, though specific results are not provided in the truncated abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: